company background image
PCR

PCC Rokita WSE:PCR Stock Report

Last Price

zł131.20

Market Cap

zł2.6b

7D

11.2%

1Y

37.1%

Updated

21 Mar, 2023

Data

Company Financials

PCR Stock Overview

PCC Rokita SA manufactures and distributes chemical products in Poland and internationally.

PCR fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance6/6
Financial Health6/6
Dividends4/6

My Notes

Capture your thoughts, links and company narrative

PCC Rokita SA Competitors

Price History & Performance

Summary of all time highs, changes and price drops for PCC Rokita
Historical stock prices
Current Share Pricezł131.20
52 Week Highzł135.80
52 Week Lowzł70.20
Beta1.11
1 Month Change10.07%
3 Month Change36.95%
1 Year Change37.10%
3 Year Change328.76%
5 Year Change16.62%
Change since IPO295.66%

Recent News & Updates

Is PCC Rokita (WSE:PCR) A Risky Investment?

Jan 18
Is PCC Rokita (WSE:PCR) A Risky Investment?

Recent updates

Is PCC Rokita (WSE:PCR) A Risky Investment?

Jan 18
Is PCC Rokita (WSE:PCR) A Risky Investment?

PCC Rokita (WSE:PCR) Is Increasing Its Dividend To zł13.23

Apr 16
PCC Rokita (WSE:PCR) Is Increasing Its Dividend To zł13.23

Why We Like The Returns At PCC Rokita (WSE:PCR)

Mar 19
Why We Like The Returns At PCC Rokita (WSE:PCR)

What Is PCC Rokita SA's (WSE:PCR) Share Price Doing?

Jan 25
What Is PCC Rokita SA's (WSE:PCR) Share Price Doing?

We Like These Underlying Return On Capital Trends At PCC Rokita (WSE:PCR)

Sep 01
We Like These Underlying Return On Capital Trends At PCC Rokita (WSE:PCR)

Why PCC Rokita SA (WSE:PCR) Could Be Worth Watching

Jun 14
Why PCC Rokita SA (WSE:PCR) Could Be Worth Watching

Are PCC Rokita SA (WSE:PCR) Investors Paying Above The Intrinsic Value?

May 18
Are PCC Rokita SA (WSE:PCR) Investors Paying Above The Intrinsic Value?

Returns On Capital At PCC Rokita (WSE:PCR) Have Hit The Brakes

Apr 13
Returns On Capital At PCC Rokita (WSE:PCR) Have Hit The Brakes

Why PCC Rokita's (WSE:PCR) Earnings Are Better Than They Seem

Mar 23
Why PCC Rokita's (WSE:PCR) Earnings Are Better Than They Seem

PCC Rokita SA's (WSE:PCR) Has Been On A Rise But Financial Prospects Look Weak: Is The Stock Overpriced?

Mar 09
PCC Rokita SA's (WSE:PCR) Has Been On A Rise But Financial Prospects Look Weak: Is The Stock Overpriced?

Looking For Steady Income For Your Dividend Portfolio? Is PCC Rokita SA (WSE:PCR) A Good Fit?

Feb 19
Looking For Steady Income For Your Dividend Portfolio? Is PCC Rokita SA (WSE:PCR) A Good Fit?

What Does PCC Rokita SA's (WSE:PCR) Share Price Indicate?

Feb 04
What Does PCC Rokita SA's (WSE:PCR) Share Price Indicate?

Is PCC Rokita (WSE:PCR) Using Too Much Debt?

Jan 15
Is PCC Rokita (WSE:PCR) Using Too Much Debt?

Should We Be Excited About The Trends Of Returns At PCC Rokita (WSE:PCR)?

Dec 30
Should We Be Excited About The Trends Of Returns At PCC Rokita (WSE:PCR)?

Reflecting on PCC Rokita's (WSE:PCR) Share Price Returns Over The Last Three Years

Dec 17
Reflecting on PCC Rokita's (WSE:PCR) Share Price Returns Over The Last Three Years

PCC Rokita SA's (WSE:PCR) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?

Dec 03
PCC Rokita SA's (WSE:PCR) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?

Are Dividend Investors Getting More Than They Bargained For With PCC Rokita SA's (WSE:PCR) Dividend?

Nov 20
Are Dividend Investors Getting More Than They Bargained For With PCC Rokita SA's (WSE:PCR) Dividend?

Shareholder Returns

PCRPL ChemicalsPL Market
7D11.2%0.3%-1.4%
1Y37.1%2.6%-13.5%

Return vs Industry: PCR exceeded the Polish Chemicals industry which returned -0.7% over the past year.

Return vs Market: PCR exceeded the Polish Market which returned -14.2% over the past year.

Price Volatility

Is PCR's price volatile compared to industry and market?
PCR volatility
PCR Average Weekly Movement4.7%
Chemicals Industry Average Movement4.8%
Market Average Movement5.1%
10% most volatile stocks in PL Market9.8%
10% least volatile stocks in PL Market3.4%

Stable Share Price: PCR is not significantly more volatile than the rest of Polish stocks over the past 3 months, typically moving +/- 5% a week.

Volatility Over Time: PCR's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
n/a1,791Wieslaw Klimkowskihttps://www.pcc.rokita.pl

PCC Rokita SA manufactures and distributes chemical products in Poland and internationally. The company offers chlorine and alkali; polyurethanes; specialty products; and surfactants products, as well as polyols, naphthalene, and phosphorus derivatives. It serves agrochemicals, adhesives, industrial cleaning and washing, detergents, paints and varnishes, tanning, glues, cosmetics and personal hygiene products, vehicle washing and care, chemical reagents, textiles, extraction and production, packaging, firefighting, construction, pulp and paper, refrigeration and household appliances, energy, pharmaceutical, furniture, metallurgical, fuel, food, mining, sport and recreation, chemical raw material and intermediates, lubricating and industrial fluids, fiber optic technologies, transport, printing inks, plastics, and water and waste water treatment industries.

PCC Rokita SA Fundamentals Summary

How do PCC Rokita's earnings and revenue compare to its market cap?
PCR fundamental statistics
Market Capzł2.60b
Earnings (TTM)zł568.76m
Revenue (TTM)zł2.82b

4.6x

P/E Ratio

0.9x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
PCR income statement (TTM)
Revenuezł2.82b
Cost of Revenuezł1.88b
Gross Profitzł938.31m
Other Expenseszł369.55m
Earningszł568.76m

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

May 16, 2023

Earnings per share (EPS)28.65
Gross Margin33.27%
Net Profit Margin20.16%
Debt/Equity Ratio46.5%

How did PCR perform over the long term?

See historical performance and comparison

Dividends

10.1%

Current Dividend Yield

46%

Payout Ratio